Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction: A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial.

NCT07288749 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07288749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07288749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction: A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial.
Lead sponsor
Tongji Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
December 31, 2031
Enrollment
1,484 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure (chf), type 2 diabetes mellitus (t2dm)